| Literature DB >> 32687087 |
Federico Franchi1, Gioia Baldini1, Marco Mautone1, Fabio S Taccone2, Paolo De Santis2, Alessandra Rocco1, Luca Marchetti1, Sabino Scolletta1.
Abstract
Context: Applanation tonometry enables the noninvasive analysis of arterial pressure wave morphology. Applanation tonometry provides the augmentation index (AIx, %), an index of arterial stiffness that partially reflects arterial-ventricular (A-V) coupling. In addition, applanation tonometry provides the dP/dt (rate of intraventricular pressure variation over time), which reflects myocardial contractility, and the sub-endocardial viability ratio (SEVR, %), which is an indicator of myocardial oxygen supply and demand. There are no data on how cardiac surgery can modify these tonometry-derived indexes. Aim: The aim was to assess changes in AIx, dP/dt, and SEVR in patients undergoing cardiac surgery. Subjects andEntities:
Keywords: Arterial stiffness; arterial tonometry; arterial vascular tone; augmentation index; cardiac surgery; dP/dt
Mesh:
Year: 2020 PMID: 32687087 PMCID: PMC7559968 DOI: 10.4103/aca.ACA_207_18
Source DB: PubMed Journal: Ann Card Anaesth ISSN: 0971-9784
Figure 1Example of aortic and radial arterial pressure wave morphology. Top (a) – Example of pressure wave morphology recorded at the level of the thoracic aorta. Bottom (b) – Example of pressure wave morphology recorded at the level of the radial artery. A = augmented pressure; D = diastolic pressure; d = dicrotic notch; An = antegrade pressure wave; R = reflected pressure wave; S = systolic pressure
Figure 2Arterial tonometer. (a) An example of the arterial tonometer (SphygmoCor, AtCor Medical, Sydney, Australia). The monitor shows the noninvasive beat-by-beat analysis of the radial artery pulse wave using applanation tonometry in a patient. (b) In the present layout, the monitor shows the reconstructed aortic arterial pressure wave (left) from a peripheral site and the tonometry-derived values (right) (see text for details)
Figure 3Graphic representation of dP/dt and of the sub-endocardial viability ratio (SEVR). (a) Graphically, dP/dt Max corresponds to the first derivative of the pressure curve in its ascendant phase. The greater the angle relative to the horizontal axis, the greater the force of ventricular contraction and/or the lower the peripheral vascular resistance. (b) The SEVR is an index of sub-endocardial perfusion. It is directly proportional to the area under the diastolic curve (AUDC) and inversely proportional to the area under the systolic curve (AUSC). SEVR = AUDC/AUSC
Clinical data, type of surgery, comorbidity, and perioperative and ICU admission data of patients
| Clinical data | |
|---|---|
| Age (years) | 68.4±21.2 |
| Weight (kg) | 78.2±17.7 |
| Sex (M/F) | 24/8 |
| Height (cm) | 168.9±7.8 |
| Body mass index (kg/cm2) | 27.3±3.9 |
| Body surface area (m2) | 1.9±0.2 |
| Ejection fraction (%) | 56.5±3.5 |
| EUROScore (points) | 6.5±3.5 |
| Type of surgery and CPB | |
| Aortic valve replacement | 8 |
| Coronary artery bypass | 5 |
| Ascending aorta replacement | 4 |
| Ascending aorta + aortic valve replacement | 8 |
| Bypass + valve | 7 |
| Cardiovascular comorbidities | |
| Arterial hypertension | 24 |
| Dyslipidemia | 12 |
| Diabetes | 8 |
| Atherosclerosis ( | 15 |
| Intraoperative variables | |
| CPB time (min) | 153.4±43.3 |
| Lactate (mmol/L) | 2.9±1.6 |
| Hematocrit (%) | 25.0±4.0 |
| Hemoglobin (g/dL) | 7.9±1.2 |
| Variables at ICU admission | |
| Blood loss (mL) | 300±175 |
| Nitrate, | 17 (53) |
| Noradrenaline, | 5 (16) |
| Dopamine, | 2 (6) |
Data are expressed as means and standard deviations or numbers and percentages. EUROScore: European System for Cardiac Operative Risk Evaluation; CPB: Cardiopulmonary bypass
Hemodynamic and metabolic variables
| T1 | T2 | T3 | |
|---|---|---|---|
| SAP (mmHg) | 120.8±19.1 | 122.6±17.6 | 121.2±19.5 |
| DAP (mmHg) | 69.7±9.6 | 66.4±12.2 | 68.3±12.9 |
| MAP (mmHg) | 87.4±10.4 | 83.9±13.1 | 85.5±13.0 |
| HR (bpm) | 64.7±11.4 | 85.0±10.9* | 83.3±11.4* |
| CVP (mmHg) | N/a | 9.8±3.5 | 10.5±2.8 |
| ScvO2 (%) | N/a | 65.7±7.4 | 63.2±7.2 |
| Hemoglobin (g/dL) | N/a | 10.5±1.6 | 10.1±1.8 |
| Lactate (mmol/L) | N/a | 2.2±1.4 | 1.4±0.4# |
Data are expressed as means and standard deviations. SAP: Systolic arterial pressure; DAP: Diastolic arterial pressure; MAP: Mean arterial pressure; HR: Heart rate; CVP: Central venous pressure; ScvO2: Central oxygen venous saturation. T1: Day before surgery; T2: Admission to ICU; T3: Discharge from ICU. *P<0.05 compared to T1; #P<0.05 compared to T2 for the variables collected only at T2 and T3
Figure 4Changes in AIx, AIx@75, dP/dt, and SEVR at the different study timepoints. AIx = augmentation index; AIx@75, AIx normalized for a HR of 75 beats per minute; dP/dt, rate of intraventricular pressure variation in time; SEVR = sub-endocardial viability ratio. T1 = day before surgery; T2 = admission to ICU; T3 = discharge from ICU. P < 0.05 compared to T1
Univariate analysis of AIx in subgroups of patients accordingly to the duration of cardiopulmonary bypass (CPB), preoperative EUROscore, type of surgery, and postoperative variables
| Variables | AIx | ANOVA | ||
|---|---|---|---|---|
| T1 | T2 | T3 | ||
| CPB time <180 min ( | 22.5±11.9 | 20.1±11.0 | 18.5±15.7 | 0.24 |
| CPB time >180 min ( | 29.75±8.4 | 9.1±15.6* | 13.6±20.5 | |
| EUROscore <6, ( | 24.8±10.7 | 14.8±16.0 | 13.6±21.9 | 0.28 |
| EUROscore >6 ( | 33.5±9.2* | 18.8±9.7 | 20.8±8.7 | |
| CABG ( | 20.6±6.1 | 15.5±5.8 | 14.7±15.5 | 0.38 |
| Other type of surgery ( | 30.4±10.9 | 16.9±14.4 | 17.4±17.7 | |
| Vasopressor or inotropic drugs ( | 28.9±5.7 | 14.8±12.6 | 12.3±19.2 | 0.55 |
| No vasopressor or inotropic drugs ( | 28.9±12.0 | 17.2±13.8 | 18.3±16.7 | |
| Lactate levels <2 at T2 ( | 28.0±11.7 | 18.0±13.4 | 18.8±15.6 | 0.70 |
| Lactate levels >2 at T2 ( | 30.2±9.7 | 14.8±13.7 | 14.3±19.5 | |
Data are expressed as means and standard deviations. *P<0.05 at univariate analysis between the groups, CABG: Coronary artery bypass graft